Adrulipase alfa

DB15004Investigational

MS-1819 is under investigation in clinical trial NCT03481803 (A Phase IIa Study With Escalating Dose of MS1819-SD).

Also known as
MS1819-SD
Code names
MS-1819

Resolves to

Compound
UNIIV6AP1D8NNW
Targets
P16233PNLIP

What you can answer from here — as of October 27, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Adrulipase alfa, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In